Navigation Links
Franklin & Seidelmann Publishes Complex Podiatry MRI Study
Date:3/11/2008

r of radiology cases reviewed by Franklin & Seidelmann enabled the group to complete the study so quickly," added Beltran.

"The ability to collect large amounts of data in few months is unique to this setting. In any other environment a clinical researcher would have to wait years before having sufficient data to validate any conclusions," he said. "In this particular study the team requested all F&S radiologists who interpret musculoskeletal ankle MRI studies to send any cases that fulfilled specific diagnostic criteria to them. In a few months they were able to have enough cases to provide a sound statistical analysis and reach significant conclusions."

The research team included musculoskeletal radiology specialists from both Franklin & Seidelmann and Maimonides Medical Center.

Franklin & Seidelmann subspecialty radiologists interpret an average of 14,000 podiatry cases on an annual basis. Comparatively, typical radiology environments process less than 2,000 cases annually. By aggregating subspecialty radiology cases across its national client base, F&S enables its radiology team to maintain and build upon their level of expertise ensuring high quality interpretations.

The Franklin & Seidelmann team includes many of the industry's leading academic subspecialty radiologists, who join in order to gain access to high case volume in order to maintain their level of expertise. Many are nationally and internationally recognized as subspecialty experts, educators, writers and lecturers. Collectively, Franklin & Seidelmann radiologists have completed more than 8,000 academic books, chapters, articles, abstracts, research awards, lectures and exhibits.

About Franklin & Seidelmann Subspecialty Radiology (F&S)

Franklin & Seidelmann Subspecialty Radiology (F&S) is a leading, national full-service teleradiology provider offering final, preliminary and subspecialty reports day or night. F&S provides clinically specific, detailed report
'/>"/>

SOURCE Franklin & Seidelmann Subspecialty Radiology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
2. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
3. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
6. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
7. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
8. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
9. Study Finds Starion Instruments Tissue Welding Technology Safe and Effective in Parotidectomy Procedures
10. Thomson Healthcare Cancer Profiler Used in Study
11. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., ST. LOUIS, Nov. 6 R...tinued to depress sales for Allied Healthcare Prod...ng September 30, 2009. ,, Sales declines pushed... for the quarter was about $745,000, or negative 9...r earlier of about $208,000, or 3 cents per share....
(Date:11/6/2009)..., WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCa...GM: DUSA), a dermatology company that is developin...py (PDT) and other products focused on patients wi...n, President and Chief Executive Officer, will pre...ord Investor Summit 2009 on Tuesday, November 10, ...
(Date:11/6/2009)..., MORRISTOWN, N.J., Nov. 6 /PRNewswire-FirstCal...a leading specialty pharmaceutical company, announ... chief executive officer, will provide an overview...t Suisse 18th Annual Healthcare Conference on Wedn...ard Time. ,, This presentation will be webcast ...
Breaking Medicine Technology:Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Precuneus region of human and monkey brain is divided into 4 distinct regions 60531 1Innovative R 26amp 3BD prioritization tool earns Baxter the 2009 INFORMS Decision Analysis Award 10602 1Innovative R 26amp 3BD prioritization tool earns Baxter the 2009 INFORMS Decision Analysis Award 10602 2North Atlantic fish populations shifting as ocean temperatures warm 10600 1North Atlantic fish populations shifting as ocean temperatures warm 10600 2North Atlantic fish populations shifting as ocean temperatures warm 10600 3
...nd Efficacy Data Reported Trial Enrol...CISCO, Calif., May 31 Sunesis,Pharmaceuticals, In...nterim,data from the company,s ongoing Phase 2 cli...in (formerly SNS-595), in platinum-resistant ovari... Clinical Oncology (ASCO),Annual Meeting in Chicag...
...vival Benefit With TORISEL Regardless of, Nephrec... Side Effects -, COLLEGEVILLE, Pa., May 31 Wyeth...), today announced results,of two new analyses of ...,rapamycin) inhibitor TORISEL(R) (temsirolimus), t...an overall survival compared with,interferon-alpha...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 2New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 3New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 4New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 5New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer 6
(Date:11/8/2009)...One victory does not mean the battle is won," said...RNewswire-USNewswire/ -- In a vote of 240-194, the...-Smith Amendment to prohibit abortion mandates and..., Americans United for Life Action President and ... amendment is a victory for the pro-life Americans...
(Date:11/8/2009)...SHINGTON, Nov. 8 Pharma...RMA) Senior Vice President Ken Johnson released th...are reform bill: ,, "We are disappointed, but n...ed by millions of hardworking Americans as well as...epresentatives who voted against the bill. ,, "...
(Date:11/8/2009)...ARP Praises House Passage of Health Care Reform Bi...edicare, improve coverage for all Americans ,,... the United States House of Representatives passed... legislation that would strengthen Medicare for se...s that prices millions of Americans out of afforda...
(Date:11/8/2009)...LLYWOOD, Calif., Nov. 8 ...on of Babies luncheon to recognize prominent indiv...dren and who are role models for March of Dimes co... of the March of Dimes November Prematurity Awaren... were urged to join the fight for preemies! ,, ...
(Date:11/7/2009)...USTON, Nov. 7, The Amer...009 Benjamin Rush Award for Citizenship and Commun...ogist from Chicago, IL. The award recognizes physi...ional call of duty to make an outstanding public s...Kraff received the award today during the opening ...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
... and Sustained Suppression of Testosterone , , P... USA today announced the U.S. commercial availabil...), a new injectable gonadotropin-releasing hormone...Degarelix is available for order through tradition...
...Eager to Work with New HHS Secretary-Designate ,...f Government Employees (AFGE), the nation,s larges...ernor Kathleen Sebelius on her nomination to becom...e reform one of the top priorities of his administ...
...ch 4 The Johnson Institute has transferred key pr...ter for Public Advocacy under an agreement reached... , (Logo: http://www.newscom.com/cgi-bin/prnh/20...ity of recovery from alcoholism and dependence on ...
...epted for publication as an original article by th...SANTA CLARA, Calif., March 4 NewCardio, Inc. (OTC...rvices company, today announced that Dr. Ihor Guss...rlando on March 29, 2009. , , Dr. Gussak, on beh...
... N.C., March 4 RIEMSER , a leading manufacturer ...und healing products, has announced an upcoming bo...ay, April 17th from 8:00 am to 1:30 pm. Cosponsore...ervation, information on bone grafting materials a...
...h 4 AirWare, Inc., maker of Brez premium nasal br...ice for inside the nose that is clinically proven ...ty for the bed partner, today released five tips t...cal sleep disorders and author of Beauty Sleep, ...
Other Medicine News:Health News:Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer 2Health News:Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer 3Health News:Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer 4Health News:Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer 5Health News:Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer 6Health News:Johnson Institute Transfers Key Programs and Products to Hazelden Foundation 2Health News:NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 2Health News:NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 3Health News:NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 4Health News:RIEMSER Announces Upcoming Atlanta Bone Grafting Workshop 2Health News:AirWare, Inc., Maker of Brez(R) Premium Breathing Aids Offers Tips for Safely and Soundly Springing Ahead During the Switch to Daylight Savings Time 2Health News:AirWare, Inc., Maker of Brez(R) Premium Breathing Aids Offers Tips for Safely and Soundly Springing Ahead During the Switch to Daylight Savings Time 3
MaxTrax Walker
Ultra Lower Leg Walker
AnkleWALKER™ by DJ!
...cast SP Walker is a short pneumatic walking brace ... Because of its shorter height it is ideal for pat...ibits them from using a standard height walker.,E...ile providing superior injury protection, support,...
Medicine Products: